Revenue
2018
2019
2020
2021
2022
2023
2024
2025
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $84.2M | $85.1M | $79.9M | $74.2M | $56.5M | $47.6M | $55.8M | $51.4M | $39.6M | $32.9M | $30.3M | $26.8M | $22.5M | $22.8M | $19.5M |
| Gross profit | $31.7M | $33.8M | $27.8M | $23.1M | $19.6M | $16.0M | $17.8M | $17.3M | $13.3M | $10.6M | $9.8M | $9.0M | $7.0M | $8.3M | $6.8M |
| Research & development | $5.0M | $4.8M | $5.0M | $4.8M | $4.4M | $4.0M | $3.8M | $3.5M | $2.9M | $4.7M | $4.0M | $4.4M | $3.8M | $3.9M | $4.4M |
| Operating expenses | $37.7M | $35.4M | $33.4M | $28.4M | $24.7M | $23.3M | $24.1M | $22.9M | $20.0M | $19.2M | $18.3M | $16.4M | $14.7M | $13.8M | $13.8M |
| Operating income | $2.6M | $7.9M | $6.0M | $5.1M | $8.3M | $1.6M | $6.6M | $8.0M | $4.6M | $1.3M | $3.2M | $6.7M | $5.0M | $4.6M | $4.6M |
| EBITDAderived | $4.3M | $9.6M | $7.7M | $6.7M | — | — | — | — | — | — | — | — | — | — | — |
| Net income | $17,619 | $5.4M | $2.9M | $6.3M | $6.3M | −$1.3M | $5.2M | $6.7M | $3.4M | −$867,514 | $1.8M | $4.1M | $3.4M | $3.4M | $3.9M |
| Basic EPSper diluted share | $0.00 | $0.57 | $0.31 | $0.69 | $0.69 | -$0.15 | $0.57 | $0.74 | $0.76 | -$0.19 | $0.40 | $0.92 | $0.76 | $0.79 | $0.90 |
| Diluted EPSper diluted share | $0.00 | $0.55 | $0.30 | $0.66 | $0.64 | -$0.15 | $0.55 | $0.72 | $0.75 | -$0.19 | $0.38 | $0.90 | $0.75 | $0.78 | $0.89 |
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| May 6, 2025Form 4 | von Falkenhausen KonstantinDirector | BuyCommon Stock | 1.1K | $7.23 | $8.0K | 18.2K |
| Apr 25, 2025Form 4 | Calderon Nancy E.Director | BuyCommon Stock | 1.0K | $7.45 | $7.5K | 8.0K |